Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > [Biochemistry] A chimeric Cre recombinase with regulated directionality

[Biochemistry] A chimeric Cre recombinase with regulated directionality

From bacterial viruses to humans, site-specific recombination and transposition are the major pathways for rearranging genomes on both long- and...

Click Here to read the entire article...

Other Articles:

•

Aradigm Presents Phase 2 Data On Inhaled Liposomal Ciprofloxacin In Cystic Fibrosis At The North American Cystic Fibrosis Conference

Aradigm Corporation (OTCBB: ARDM) it is presenting data from its Phase 2 study of inhaled liposomal ciprofloxacin (ARD-3100) in cystic fibrosis (CF) patients at the 22nd Annual North American Cystic Fibrosis (NACF) conference in Orlando, Florida. Completed in June 2008, the study was an open-label, two week efficacy and safety trial of once daily inhaled liposomal ciprofloxacin in 22 CF patients conducted at leading CF centers in Australia and New Zealand.

Click Here to read the entire article...

•

Listen to The Lancet: 11 October

Listen to Vikram Patel in this week's podcast and visit the website of the Movement for Global Mental Health for further information.

Click Here to read the entire article...

•

The ASCB Needs You!

Added a new document entitled The ASCB Needs You! This document outlines all of the opportunities that are available to you for volunteering.

Click Here to read the entire article...

•

ZOOM RHYTHMTRAK RT323

£75.00 (0 Bid)
End Date: Sunday Nov-23-2008 21:20:02 GMT
Bid now | Add to watch list

Click Here to read the entire article...

•

Medtech Startups, January 2008

New medical technologies represented in companies added (January 2008) to the Medtech Startups Database and/or added to the January 2008 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December:

Treatment of neurological and psychiatric disorders by, for example, electrical stimulation.
Developing technologies to visualize vascular junctions in order to enhance ablation in treatment of atrial fibrillation.
Technologies for embolic cerebral protection to reduce embolic stroke during interventional procedures.
Ophthalmic technologies targeting vision loss.
Developing a device for retro-muscular mesh placement in hernia repair.
Femoral head resurfacing implant with internal fixation and instrumentation.
Materials to enhance in situ tissue regeneration.
Integrated insulin pump and glucose monitor for insulin-dependent diabetes.
MRI-guided robotic breast cancer intervention.
Nanoparticle-based delivery of chemotherapeutic agents for cancer.
Ophthalmic device technologies.
Device technologies to enhance left ventricular assist device (LVAD) implantation.
Motion preserving spine fusion implant, inserted minimally invasively, for treatment of degenerative disc disease.
Device technology to reduce incisions in laparoscopic surgery.

Now Published!: Worldwide Wound Management 2007-2016. see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup

Click Here to read the entire article...

•

Clinical Trials Update: Nov. 14, 2008 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Click Here to read the entire article...